Wellington Management Group LLP Trims Stock Position in Calumet, Inc. $CLMT

Wellington Management Group LLP lessened its stake in shares of Calumet, Inc. (NASDAQ:CLMT) by 2.3% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 811,482 shares of the oil and gas company’s stock after selling 19,076 shares during the period. Wellington Management Group LLP’s holdings in Calumet were worth $29,230,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the company. Islay Capital Management LLC purchased a new stake in shares of Calumet in the 4th quarter worth $25,000. Aster Capital Management DIFC Ltd raised its holdings in shares of Calumet by 294.7% in the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock valued at $33,000 after acquiring an additional 1,229 shares in the last quarter. Global Retirement Partners LLC bought a new stake in shares of Calumet in the second quarter valued at about $61,000. KBC Group NV purchased a new stake in Calumet in the first quarter worth about $69,000. Finally, Covestor Ltd lifted its stake in Calumet by 29.1% in the fourth quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock worth $43,000 after acquiring an additional 492 shares during the period. Hedge funds and other institutional investors own 34.41% of the company’s stock.

Calumet Stock Performance

Shares of Calumet stock opened at $53.13 on Friday. The company has a market capitalization of $4.67 billion, a PE ratio of -34.28 and a beta of 0.72. The company has a 50-day simple moving average of $43.76 and a two-hundred day simple moving average of $36.21. Calumet, Inc. has a one year low of $16.75 and a one year high of $54.69.

Calumet (NASDAQ:CLMT) last released its quarterly earnings results on Friday, August 7th. The oil and gas company reported ($1.09) earnings per share for the quarter, missing analysts’ consensus estimates of $0.07 by ($1.16). The firm had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.12 billion. During the same quarter in the prior year, the company earned ($1.70) EPS. The business’s quarterly revenue was up 40.8% on a year-over-year basis. On average, equities analysts predict that Calumet, Inc. will post 0.48 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. The Goldman Sachs Group boosted their price target on shares of Calumet from $40.00 to $45.00 and gave the company a “neutral” rating in a report on Tuesday, August 18th. Weiss Ratings reissued a “sell (d-)” rating on shares of Calumet in a report on Friday, August 7th. TD Cowen boosted their price objective on shares of Calumet from $34.00 to $40.00 and gave the stock a “hold” rating in a research note on Wednesday, August 12th. Citigroup restated a “buy” rating on shares of Calumet in a report on Monday, August 10th. Finally, HC Wainwright lifted their price target on Calumet from $60.00 to $75.00 and gave the company a “buy” rating in a report on Wednesday. Two investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Calumet has a consensus rating of “Hold” and an average price target of $51.75.

Insider Buying and Selling

In other Calumet news, Director Daniel Sajkowski sold 4,240 shares of the firm’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $36.16, for a total value of $153,318.40. Following the completion of the sale, the director directly owned 77,718 shares in the company, valued at $2,810,282.88. This trade represents a 5.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 3.15% of the stock is owned by insiders.

More Calumet News

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: HC Wainwright raised its earnings forecasts and maintained a Buy rating. The firm increased its Q3 2026 EPS estimate to $0.62 from $0.60, Q4 to $0.24 from $0.22, FY2026 to $0.17 from $0.12, and FY2027 to $1.11 from $0.59. Its $75 price target implies substantial upside from the stock’s recent trading level. HC Wainwright earnings estimate report
• Positive Sentiment: The upward revisions suggest HC Wainwright expects stronger profitability over the next several quarters, potentially reflecting improved operating performance or business conditions. The revised FY2027 forecast is notably above the broader current-year consensus estimate of $0.46 per share. Calumet stock price expected to rise
• Neutral Sentiment: Calumet announced plans to attend the H.C. Wainwright conference. The event could provide investors with updates on strategy and operations, but no new financial information was disclosed in the announcement. Calumet conference announcement
• Neutral Sentiment: A Zacks analysis compared Calumet’s year-to-date performance with TXO Partners and the broader oil-and-energy sector. The article provides relative-performance context but does not indicate a new company-specific catalyst. Zacks Calumet sector performance analysis
• Negative Sentiment: Pomerantz LLP announced an investigation into potential claims on behalf of Calumet investors. Although the announcement does not establish wrongdoing, the prospect of litigation or regulatory concerns may weigh on sentiment and introduce uncertainty. Pomerantz investor investigation

Calumet Company Profile

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.